Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c; Offers FY22 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. KBH
3. FDX
4. HONA
5. HTZ
6. HON
7. TTWO
8. HELP
9. GDYN
10. NKE

Go back to Karyopharm Therapeutics (KPTI) Tops Q2 EPS by 1c; Offers FY22 Revenue Guidance
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 9.65 --0 (-0%)
Previous Close $9.65    52 Week High $19.41 
Open $9.65    52 Week Low $4.83 
Day High $9.65    P/E N/A 
Day Low $9.65    EPS $-2.74 
Volume 1,638